2023 Surgery Grand Rounds | Bryan and Helga Isaacs Distinguished Lectureship in Head and Neck Cancer at City of Hope: Developing Biomarkers to Predict Outcome in Head and Neck Squamous Cell Carcinoma
Helga Isaacs was a patient with oropharyngeal cancer (OPC), cured of her disease but fraught with life-long complications associated with her prior cancer therapies. Although she was without cancer, she was a speech and swallow disabled person, and this impacted every aspect of her life. This activity is inspired by her memory and our commitment to improve our understanding of her disease and betterment of our treatment strategies for head and neck cancer patients to better serve our patients’ overall happiness and fulfillment in life.
There is a need for up-to-date trends on diagnosis and management of head and neck cancer patients. Discussion of state-of-the-art science and technologies, report on clinical trials and pertinent research is imperative to keep our clinicians abreast of ideal practice. Opportunities for new research collaborations through this activity will increase knowledge, competence, and performance.
The head and neck cancers multidisciplinary team: surgeons, NP’s, PA’s, medical oncologists, radiation oncologists, immunologists, radiologists and all other health care professionals interested in this subject matter.
- Identify the role of estrogen receptor alpha (ERα) as a biomarker of therapeutic outcome in HPV-related oropharyngeal cancer.
- Examine how tumor genetic progression with the identification of early genetic events can be inferred with high accuracy through exome sequencing and PhylogicNDT analysis of established tumors, even in cancers with unobtainable premalignant tissue.
Virtual Meeting- Zoom
James W. Rocco, MD, PhD, FACS Professor and Chair, Department of Otolaryngology – Head and Neck Surgery, Ohio State University; The Mary E. and John W. Alford Research Chair in Head and Neck Cancer; Director, Head and Neck Disease Specific Research Group; James Comprehensive Cancer Center
Presenter: Dr. Rocco has indicated that there are no relevant financial relationships.
Planner: Ellie Maghami, MD has indicated that there are no relevant financial relationships.
This presentation and/or comments will provide a balanced, non-promotional, and evidence-based approach to all diagnostic, therapeutic and/or research related content.
CME Committee/Reviewer no relevant financial relationships: Daneng Li, MD
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABS credit.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2023 Surgery Grand Rounds | Bryan and Helga Isaacs Distinguished Lectureship in Head and Neck Cancer at City of Hope: Developing Biomarkers to Predict Outcome in Head and Neck Squamous Cell Carcinoma for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance